Mechanism of thrombocytosis in hepatoblastoma: A case report

Pediatric Hematology and Oncology

Volumn 13, Issue 6, 1996, Pages 539-544

  Yamaguchi, Hideto ^a   Ishii, Eiichi ^a   Hayashida, Yutaka ^a   Hirata, Yuzo ^a   Sakai, Ryo ^a   Miyazaki, Sumio ^b  

^a Saga Medical School   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

hepatoblastoma; thrombocytosis; thrombopoietin (Tpo)

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; MELPHALAN; THROMBOPOIETIN;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; LIVER RESECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTOSIS;

EID: 0029908964     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609030869     Document Type: Article

References (18)

1. Vora AJ, Lilleyman JS. Secondary thrombocytosis. Arch Dis Child. 1993;68:88-90.
2. Nickerson HJ, Silberman TI, McDonald TP. Hepatoblastoma, thrombocytosis and increased thrombopoietin. Cancer. 1980;45:315-317.
3. Shafford EA, Pritchard J. Extreme thrombocytosis as a diagnostic clue to hepatoblastoma. Arch Dis Child. 1993;69:171.
4. Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994;369:568-574.
5. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994;369:533-538.
6. Banu N, Wang J, Deng B, Groopman JE, Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood. 1995;86:1331-1338.
7. Kato T, Ogami K, Shimada Y, et al. Purification and characterization of thrombopoietin. J Biochem (Tokyo). 1995;118:229-236.
8. Tahara T, Usuki K, Sato H, et al. Serum thrombopoietin in healthy volunteers and patients with various disorders measured by enzyme immunoassay. Blood. 1995;86(suppl 1):910a.
9. Gewirtz AM, Hoffman R. Human megakaryocyte production: cell biology and clinical considerations. Hematol Oncol Clin North Am. 1990;4:43-64.
10. Guinan EC, Lee YS, Lopez KD, et al. Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia. Blood. 1993;81:1691-1698.
11. Imai T, Koike K, Kubo T, et al. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood. 1991;78:1969-1974.
12. Debili N, Wendling F, Katz A, et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiation factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 1995;86:2516-2525.
13. Broudy VC, Kaushansky K. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J Leukoc Biol. 1995;57:719-725.
14. Nichol JL, Hokom MM, Hornkohl A, et al. Megakaryocyte growth and development factor. J Clin Invest 1995;95:2973-2978.
15. Kawakita M, Ogawa M, Goldwasser E, Miyake T. Characterization of human megakaryocyte colony-stimulating factor in the urinary extracts from patients with aplastic anemia and idiopathic thrombocytopenic purpura. Blood. 1983;61:556-560.
16. Hill R, Levin J. Partial purification of thrombopoietin using lectin chromatography. Exp Hematol. 1986;14:752-759.
17. McCarty JM, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood. 1994;84(suppl 1):241a.
18. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA. 1994;91:11104-11108.